The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Abstract
Abdominal fat accumulation has been shown to play crucial roles in the development of metabolic syndrome. Visceral fat accumulation particularly is closely correlated to the development of cardiovascular disease and obesity-related disorders such as diabetes mellitus, hyperlipidemia and hypertension. Given these clinical findings, the functions of adipocytes have been intensively investigated in the past 10 years, and have been revealed to act as endocrine cells that secrete various bioactive substances termed adipocytokines. Among adipocytokines, tumor-necrosis factor-alpha, plasminogen activator inhibitor type 1 and heparin-binding epidermal growth factor-like growth factor are produced in adipocytes as well as other organs, and contribute to the development of vascular diseases. Visfatin has been identified as a visceral-fat-specific protein that might be involved in the development of obesity-related diseases, such as diabetes mellitus and cardiovascular disease. In contrast to these adipocytokines, adiponectin, which is an adipose-tissue-specific, collagen-like protein, has been noted as an important antiatherogenic and antidiabetic protein, or as an anti-inflammatory protein. The functions of adipocytokine secretion might be regulated dynamically by nutritional state. Visceral fat accumulation causes dysregulation of adipocyte functions, including oversecretion of tumor-necrosis factor-alpha, plasminogen activator inhibitor type 1 and heparin-binding epidermal growth factor-like growth factor, and hyposecretion of adiponectin, which results in the development of a variety of metabolic and circulatory diseases. In this review, the importance of adipocytokines, particularly adiponectin, is discussed with respect to cardiovascular diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Witham et al. (751) provided 100 000 IU (2500 mg) vitamin D 2 or placebo to elderly patients with systolic heart failure at study entry (week 0) and after 10 weeks and found no effect on plasma TNF-a at 10 or 20 weeks.”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [751]
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
Self-citationRetractedRole of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Self-citationDeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Self-citationAdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Cited by
Sorted by citations
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Obesity as a Major Risk Factor for Cancer
Pergola, G. D., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 1,007
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Mahabadi, A. A., Massaro, J. M., Rosito, G. A., Levy, D. A., Murabito, J. M., Wolf, P. A., O’Donnell, C. J., Fox, C. S., & Hoffmann, U. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn573 · Cited by 655
Adiponectin regulates albuminuria and podocyte function in mice
Sharma, K., RamachandraRao, S., Qiu, G., Usui, H. K., Zhu, Y., Dunn, S., Ouedraogo, R., Hough, K., McCue, P. A., Chan, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32691 · Cited by 609
Adipokines as emerging mediators of immune response and inflammation
Lago, F., Diéguez, C., Gómez-Reino, J. J., & Gualillo, O. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0674 · Cited by 569
The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases
Balistreri, C. R., Caruso, C., & Candore, G. (2010) · Mediators of Inflammation · doi:10.1155/2010/802078 · Cited by 576
The metabolic syndrome and adipocytokines
Matsuzawa, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.028 · Cited by 541
Self-citationBays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 543
Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women
Ko, S., & Kim, H. (2020) · Nutrients · doi:10.3390/nu12010202 · Cited by 561
Matsuzawa, Y., Funahashi, T., & Nakamura, T. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7922 · Cited by 458
Self-citationNishimura, S., Manabe, I., Nagasaki, M., Hosoya, Y., Yamashita, H., Fujita, H., Ohsugi, M., Tobe, K., Kadowaki, T., Nagai, R., et al. (2007) · Diabetes · doi:10.2337/db06-1749 · Cited by 440
Maejima, Y., Sedbazar, U., Suyama, S., Kohno, D., Onaka, T., Takano, E., Yoshida, N., Koike, M., Uchiyama, Y., Fujiwara, K., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.002 · Cited by 317
Cardiac Energy Metabolism in Obesity
Lopaschuk, G. D., Folmes, C. D. L., & Stanley, W. C. (2007) · Circulation Research · doi:10.1161/circresaha.107.150417 · Cited by 309
PPARs, Obesity, and Inflammation
Stienstra, R., Duval, C., Müller, M., & Kersten, S. (2007) · PPAR Research · doi:10.1155/2007/95974 · Cited by 287
Adiponectin is a novel humoral vasodilator
Fésüs, G., Dubrovska, G., Gorzelniak, K., KLUGE, R., Huang, Y., Luft, F. C., & Gollasch, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.025 · Cited by 276
Housa, D., Housova, J., Vernerová, Z., & Haluzı́k, M. (2006) · Physiological Research · doi:10.33549/physiolres.930848 · Cited by 265
A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq dataPreprint
Alghamdi, N., Chang, W., Dang, P., Lu, X., Wan, C., Gampala, S., Huang, Z., Wang, J., Ma, Q., Zang, Y., et al. (2021) · Genome Research · doi:10.1101/gr.271205.120 · Cited by 271
Spiroglou, S. G., Kostopoulos, C. G., Varakis, J. N., & Papadaki, H. H. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.1735 · Cited by 239
Angiogenesis and development of adipose tissue
Christiaens, V., & LIJNEN, H. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.006 · Cited by 247
Wang, C., Hsu, H., Hung, W., Yu, T., Chen, Y., Chiu, C., Lu, L., Chung, F., Shin, S., & Lee, Y. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03411.x · Cited by 229
Overview of Adipose Tissue and Its Role in Obesity and Metabolic Disorders
Frühbeck, G. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-245-8_1 · Cited by 233
Adipokines oversecreted by omental adipose tissue in human obesity
Maury, E., Ehala-Aleksejev, K., Guiot, Y., Détry, R., Vandenhooft, A., & Brichard, S. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00127.2007 · Cited by 212
Insulin resistance, insulin response, and obesity as indicators of metabolic risk
Ferrannini, E., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Nolan, J., Walker, M., Natali, A., & Beck-Nielsen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0334 · Cited by 193
Reproductive and Metabolic Phenotype of a Mouse Model of PCOS
van Houten, E. L. A. F., Kramer, P., McLuskey, A., Karels, B., Themmen, A. P. N., & Visser, J. A. (2012) · Endocrinology · doi:10.1210/en.2011-1754 · Cited by 190
Elevated Serum Levels of Pigment Epithelium-Derived Factor in the Metabolic Syndrome
Yamagishi, S., Adachi, H., Abe, A., Yashiro, T., Enomoto, M., Furuki, K., Hino, A., Jinnouchi, Y., Takenaka, K., Matsui, T., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2654 · Cited by 181
Developmental Origins of Obesity: Programmed Adipogenesis
Desai, M., Beall, M., & Ross, M. G. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0344-x · Cited by 171
‘Metabolically healthy obesity’: Origins and implications
Denis, G. V., & Obin, M. S. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.004 · Cited by 176
Establishment of a concept of visceral fat syndrome and discovery of adiponectin
Matsuzawa, Y. (2010) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.86.131 · Cited by 164
Self-citationAdipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose Metabolism
Enomoto, T., Ohashi, K., Shibata, R., Higuchi, A., Maruyama, S., Izumiya, Y., Walsh, K. X., Murohara, T., & Ouchi, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277319 · Cited by 155
Circulating omentin is associated with coronary artery disease in men
Shibata, R., Ouchi, N., Kikuchi, R., Takahashi, R., Takeshita, K., Kataoka, Y., Ohashi, K., Ikeda, N., Kihara, S., & Murohara, T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.017 · Cited by 148
Prevalence of Metabolic Syndrome in the General Japanese Population in 2000
Arai, H., Yamamoto, A., Matsuzawa, Y., Saitō, Y., Yamada, N., Oikawa, S., Mabuchi, H., Teramoto, T., Sasaki, J., Nakaya, N., et al. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.202 · Cited by 149
Self-citationThe novel adipocytokine visfatin exerts direct cardioprotective effects
Lim, S. Y., Davidson, S. M., Paramanathan, A. J., Smith, C., Yellon, D. M., & Hausenloy, D. J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00332.x · Cited by 148
Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation
Totoń‐Żurańska, J., Mikolajczyk, T. P., Saju, B., & Guzik, T. J. (2024) · Clinical Science · doi:10.1042/cs20220797 · Cited by 156
Decreases in Serum Triacylglycerol and Visceral Fat Mediated by Dietary Soybean .BETA.-conglycinin
Kohno, M., Hirotsuka, M., Kito, M., & Matsuzawa, Y. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.247 · Cited by 141
Self-citationCaligiuri, A., Bertolani, C., Guerra, C. T., Aleffi, S., Galastri, S., Trappoliere, M., Vizzutti, F., Gelmini, S., Laffi, G., Pinzani, M., et al. (2007) · Hepatology · doi:10.1002/hep.21995 · Cited by 139
Omentin as a novel biomarker of metabolic risk factors
Shibata, R., Ouchi, N., Takahashi, R., Terakura, Y., Ohashi, K., Ikeda, N., Higuchi, A., Terasaki, H., Kihara, S., & Murohara, T. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-37 · Cited by 133
Psoriasis and metabolic syndrome
Takahashi, H., & Iizuka, H. (2011) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01408.x · Cited by 134
Conde, J., Scotece, M., Gómez, R., Lopez, V., Gómez-Reino, J. J., & Gualillo, O. (2011) · Arthritis · doi:10.1155/2011/203901 · Cited by 132
Subfatin is a Novel Adipokine and Unlike Meteorin in Adipose and Brain Expression
Li, Z., Zheng, S., Wang, P., Xu, T., Guan, Y., Zhang, Y., & Miao, C. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12219 · Cited by 131
Metabolic disorders in menopause
Stachowiak, G., Pertyński, T., & Pertyńska−Marczewska, M. (2015) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2015.50000 · Cited by 142
Shirouchi, B., Nagao, K., Inoue, N., Ohkubo, T., Hibino, H., & Yanagita, T. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071225x · Cited by 131
de la Torre, N. G., Rubio, M. Á., Bordiú, E., Cabrerizo, L., Aparicio, E., Hernández, C., Sánchez-Pernaute, A., Díez-Valladares, L. I., Torres, A. J., Puente, M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1370 · Cited by 126
Murase, T., Haramizu, S., Ota, N., & Hase, T. (2009) · Biogerontology · doi:10.1007/s10522-008-9177-z · Cited by 125
The role of fat topology in the risk of disease
Matsuzawa, Y. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.243 · Cited by 125
Self-citationClinical and laboratory diagnosis of the metabolic syndrome
Olufadi, R., & Byrne, C. D. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048363 · Cited by 123
Update on the pathophysiology of liver fibrosis
Pinzani, M., & Macías‐Barragán, J. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.47 · Cited by 126
Hiuge, A., Tenenbaum, A., Maeda, N., Benderly, M., Kumada, M., Fisman, E. Z., Tanné, D., Matas, Z., Hibuse, T., Fujita, K., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000256469.06782.d5 · Cited by 122
Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis
Fujishima, Y., Maeda, N., Matsuda, K., Masuda, S., Mori, T., Fukuda, S., Sekimoto, R., Yamaoka, M., Obata, Y., Kita, S., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601064r · Cited by 119
Sun, G., Bishop, J., Khalili, S., Vasdev, S., Gill, V. D., Pace, D., Fitzpatrick, D., Randell, E. W., Xie, Y., & Zhang, H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.399 · Cited by 117
Ingelsson, E., Sundström, J., Melhus, H., Michaëlsson, K., Berne, C., Vasan, R. S., Risérus, U., Blomhoff, R., Lind, L., & Ärnlöv, J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.029 · Cited by 114
Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox
Neves, K. B., Nguyen Dinh Cat, A., Lopes, R. A. M., Rios, F. J., Anagnostopoulou, A., Lobato, N. S., de Oliveira, A. M., Tostes, R. C., Montezano, A. C., & Touyz, R. M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05616 · Cited by 113
Mahadev, K., Wu, X., Donnelly, S., Ouedraogo, R., Eckhart, A. D., & Goldstein, B. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn034 · Cited by 112
Qin, B., Polansky, M. M., Dawson, H. D., & Anderson, R. A. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900306 · Cited by 109
Uemura, Y., Shibata, R., Ohashi, K., Enomoto, T., Kambara, T., Yamamoto, T., Ogura, Y., Yuasa, D., Joki, Y., Matsuo, K., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-213744 · Cited by 109
Relationship between Metabolic Syndrome and Uterine Leiomyomas: A Case-Control Study
Takeda, T., Sakata, M., Isobe, A., Miyake, A., Nishimoto, F., Ota, Y., Kamiura, S., & Kimura, T. (2008) · Gynecologic and Obstetric Investigation · doi:10.1159/000114250 · Cited by 109
Park, H.-J., Jung, U. J., Cho, S.-J., Jung, H.-K., Shim, S., & Choi, M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.009 · Cited by 108
Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9
Maeda, N., Funahashi, T., & Shimomura, I. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0980 · Cited by 111
Matsuda, K., Fujishima, Y., Maeda, N., Mori, T., Hirata, A., Sekimoto, R., Tsushima, Y., Masuda, S., Yamaoka, M., Inoue, K., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1618 · Cited by 104
Yan, Z. C., Liu, D. Y., Zhang, L. L., Shen, C., Li, Q., Cao, T. B., Wang, L., Nie, H., Zidek, W., Tepel, M., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.213 · Cited by 105
Bays, H. E., Blonde, L., & Rosenson, R. S. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.871 · Cited by 103
Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice
Hiramatsu‐Ito, M., Shibata, R., Ohashi, K., Uemura, Y., Kanemura, N., Kambara, T., Enomoto, T., Yuasa, D., Matsuo, K., Ito, M., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv282 · Cited by 106
Nakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.09.004 · Cited by 96
Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases
Gómez, R., Lago, F., Gómez-Reino, J. J., Diéguez, C., & Gualillo, O. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0131 · Cited by 94
Adiponectin and Leptin: New Targets in Inflammation
Scotece, M., Conde, J., López, V., Lago, F., Pino, J., Gómez-Reino, J. J., & Gualillo, O. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12109 · Cited by 93
The role of adipokines in cardiovascular disease
Shibata, R., Ouchi, N., Ohashi, K., & Murohara, T. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.02.006 · Cited by 97
Melatonin reduces obesity and restores adipokine patterns and metabolism in obese ( ob/ob ) mice
Favero, G., Stacchiotti, A., Castrezzati, S., Bonomini, F., Albanese, M., Rezzani, R., & Rodella, L. F. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.07.001 · Cited by 92
The Obesity Epidemic: Current and Future Pharmacological Treatments
Hofbauer, K. G., Nicholson, J. R., & Boss, O. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105256 · Cited by 89
Oncostatin M Inhibits Adipogenesis through the RAS/ERK and STAT5 Signaling Pathways
Miyaoka, Y., Tanaka, M., Naiki, T., & Miyajima, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606089200 · Cited by 89
Association of Epicardial, Visceral, and Subcutaneous Fat With Cardiometabolic Diseases
Sato, F., Maeda, N., Yamada, T., Namazui, H., Fukuda, S., Natsukawa, T., Nagao, H., Murai, J., Masuda, S., Tanaka, Y., et al. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0820 · Cited by 89
Inflammatory pathways in children with insufficient or disordered sleep
Kim, J., Hakim, F., Gozal, D., & Gozal, D. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.04.024 · Cited by 92
Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis
Nishida, M., Moriyama, T., Ishii, K., Takashima, S., Yoshizaki, K., Sugita, Y., & Yamauchi-Takihara, K. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.06.009 · Cited by 86
C1q/TNF‐related protein‐1 functions to protect against acute ischemic injury in the heart
Yuasa, D., Ohashi, K., Shibata, R., Mizutani, N., Kataoka, Y., Kambara, T., Uemura, Y., Matsuo, K., Kanemura, N., Hayakawa, S., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-279885 · Cited by 83
Plasma Concentration of Pigment Epithelium-Derived Factor in Patients with Diabetic Retinopathy
Ogata, N., Matsuoka, M., Matsuyama, K., Shima, C., Tajika, A., Nishiyama, T., Wada, M., Jo, N., Higuchi, A., Minamino, K., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2249 · Cited by 82
Providencia, R. A., Adragão, P., de Asmundis, C., Chun, K. R. J., Chierchia, G., Defaye, P., Anselme, F., Creta, A., Lambiase, P. D., Schmidt, B., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012253 · Cited by 79
Maury, E., Noël, L., Detry, R. J., & Brichard, S. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2196 · Cited by 83
Arai, Y., Takayama, M., Abe, Y., & Hirose, N. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7039 · Cited by 78
Hotta, K., Kitamoto, T., Kitamoto, A., Mizusawa, S., Matsuo, T., Nakata, Y., Kamohara, S., Miyatake, N., Kotani, K., Komatsu, R., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.74 · Cited by 79
Self-citationPerinatal Circulating Visfatin Levels in Intrauterine Growth Restriction
Malamitsi‐Puchner, A., Briana, D. D., Boutsikou, M., Kouskouni, E. E., Hassiakos, D., & Gourgiotis, D. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2589 · Cited by 78
Rodrigues, A. L., de Moura, E. G., Passos, M. C. F., Trevenzoli, I. H., da Conceição, E. P. S., Bonomo, I. T., Neto, J. F. N., & Lisboa, P. C. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.013 · Cited by 84
Beyond Fat Mass: Exploring the Role of Adipokines in Rheumatic Diseases
Scotece, M., Conde, J., Gómez, R., López, V., Lago, F., Gómez-Reino, J. J., & Gualillo, O. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/290142 · Cited by 74
Adiposopathy: why do adiposity and obesity cause metabolic disease?
Bays, H. E., & Ballantyne, C. M. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.389 · Cited by 75
Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
Anfossi, G., Russo, I., Doronzo, G., Pomero, A., & Trovati, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/174341 · Cited by 76
Role of PET in the evaluation and understanding of coronary physiology
Schindler, T. H., Zhang, X., Vincenti, G. M., Mhiri, L., Lerch, R. A., & Schelbert, H. R. (2007) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.05.006 · Cited by 74
Antioxidant Supplementation Lowers Exercise‐Induced Oxidative Stress in Young Overweight Adults
Vincent, H. K., Bourguignon, C. M., Vincent, K. R., WELTMAN, A. L., Bryant, M., & Taylor, A. G. (2006) · Obesity · doi:10.1038/oby.2006.261 · Cited by 73
Wu, X., Mahadev, K., Fuchsel, L., Ouedraogo, R., Xu, S., & Goldstein, B. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00115.2007 · Cited by 75
Liang, W. H., & Ye, D. D. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.06.002 · Cited by 75
Study of the proinflammatory role of human differentiated omental adipocytes
Bassols, J., Ortega, F. J., Moreno‐Navarrete, J. M., Peral, B., Ricart, W., & Fernández‐Real, J. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22208 · Cited by 70
Figueroa, A. L., Takx, R. A. P., MacNabb, M. H., Abdelbaky, A., Lavender, Z. R., Kaplan, R. S., Truong, Q. A., Lo, J., Ghoshhajra, B. B., Grinspoon, S. K., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004043 · Cited by 70
Adipokines and Aging: Findings From Centenarians and the Very Old
Arai, Y., Kamide, K., & Hirose, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00142 · Cited by 71
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy
SHARMA, N., Okere, I. C., Duda, M. K., Chess, D. J., O’Shea, K. M., & Stanley, W. C. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.007 · Cited by 69
Adipose‐derived protein omentin prevents neointimal formation after arterial injury
Uemura, Y., Shibata, R., Kanemura, N., Ohashi, K., Kambara, T., Hiramatsu‐Ito, M., Enomoto, T., Yuasa, D., Joki, Y., Matsuo, K., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-258129 · Cited by 67
Shibata, R., Takahashi, R., Kataoka, Y., Ohashi, K., Ikeda, N., Kihara, S., Murohara, T., & Ouchi, N. (2011) · Hypertension Research · doi:10.1038/hr.2011.130 · Cited by 67
Wang, Y., Chen, D., Zhang, Y., Wang, P., Zheng, C., Zhang, S., Yu, B., Zhang, L., Zhao, G., Ma, B., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032398 · Cited by 68
Placental cytokines and preeclampsia
Keelan, J. A. (2006) · Frontiers in bioscience · doi:10.2741/2266 · Cited by 69
Exercise-Induced Irisin, the Fat Browning Myokine, as a Potential Anticancer Agent
Maalouf, G.-E., & Khoury, D. E. (2019) · Journal of Obesity · doi:10.1155/2019/6561726 · Cited by 69
Arai, Y., Takayama, M., Gondo, Y., Inagaki, H., Yamamura, K., Nakazawa, S., Kojima, T., Ebihara, Y., Shimizu, K., Masui, Y., et al. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.11.1209 · Cited by 66
Metadata
- Authors
- Matsuzawa, Y.
- Venue
- Nature Clinical Practice Cardiovascular Medicine
- Published
- 2006-01
- Volume
- 3
- Issue
- 1
- Pages
- 35-42
- ISSN
- 1743-4297 (ISSN-L)
- 1743-4300
- OpenAlex
- W2060823593
- Cited by
- 434
- References
- 60
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 12 · 2019: 13 · 2018: 9 · 2017: 19 · 2016: 15 · 2015: 24 · 2014: 30 · 2013: 25 · 2012: 33
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Cardiovascular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adipokines, metabolic syndrome, cardiovascular disease, adiponectin, TNF-α, plasminogen activator inhibitor-1, HB-EGF, visfatin, visceral fat, obesity, diabetes mellitus, atherosclerosis, anti-inflammatory activity
- MeSH terms
- Adipose Tissue, Cardiovascular Diseases, Humans, Risk Factors, Cytokines, Metabolic Syndrome, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review